Stock NH NARAYANA HRUDAYALAYA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Narayana Hrudayalaya Limited

Equities

NH

INE410P01011

Healthcare Facilities & Services

Market Closed - NSE India S.E.
Other stock markets
 07:43:48 2024-04-26 am EDT 		5-day change 1st Jan Change
1,276 INR +0.71% Intraday chart for Narayana Hrudayalaya Limited +2.66% +6.12%
Apr. 25 Narayana Hrudayalaya Acquires Bengaluru, India Land for Business Expansion MT
Feb. 26 Narayana Hrudayalaya Secures Land in Kolkata, India to House Healthcare Facility MT

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 43,042 50,194 82,344 151,244 157,118 259,016 - -
Enterprise Value (EV) 1 49,403 55,340 86,276 155,444 160,942 262,650 264,390 258,923
P/E ratio 72.8 x 42.2 x -580 x 44.3 x 25.9 x 32.2 x 30.7 x 27.4 x
Yield 0.47% 0.4% 0.25% 0.13% 0.32% 0.14% 0.14% 0.16%
Capitalization / Revenue 1.5 x 1.6 x 3.19 x 4.09 x 3.47 x 5.08 x 4.47 x 3.96 x
EV / Revenue 1.73 x 1.77 x 3.34 x 4.2 x 3.56 x 5.15 x 4.56 x 3.96 x
EV / EBITDA 17.2 x 13.1 x 47.4 x 23.8 x 16.7 x 22.4 x 20.1 x 16.8 x
EV / FCF 38.4 x 16.9 x 36.1 x 66.3 x 28.6 x 2,250 x 89 x 44.6 x
FCF Yield 2.6% 5.92% 2.77% 1.51% 3.5% 0.04% 1.12% 2.24%
Price to Book 4.02 x 4.45 x 7.4 x 10.1 x 7.38 x 8.93 x 7.19 x 5.65 x
Nbr of stocks (in thousands) 202,407 202,804 202,892 202,917 202,956 203,070 - -
Reference price 2 212.6 247.5 405.8 745.4 774.2 1,276 1,276 1,276
Announcement Date 5/24/19 6/15/20 5/31/21 5/20/22 5/19/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 28,609 31,278 25,823 37,013 45,248 50,991 57,955 65,385
EBITDA 1 2,878 4,229 1,821 6,535 9,658 11,706 13,172 15,426
EBIT 1 1,505 2,371 -14.26 4,700 7,558 9,361 10,389 12,397
Operating Margin 5.26% 7.58% -0.06% 12.7% 16.7% 18.36% 17.93% 18.96%
Earnings before Tax (EBT) 1 957.3 1,647 -492.3 4,383 7,518 9,052 10,056 12,002
Net income 1 591.7 1,189 -143 3,419 6,062 8,089 8,368 9,451
Net margin 2.07% 3.8% -0.55% 9.24% 13.4% 15.86% 14.44% 14.45%
EPS 2 2.920 5.860 -0.7000 16.84 29.85 39.66 41.52 46.52
Free Cash Flow 1 1,286 3,275 2,390 2,343 5,625 116.8 2,969 5,803
FCF margin 4.5% 10.47% 9.25% 6.33% 12.43% 0.23% 5.12% 8.88%
FCF Conversion (EBITDA) 44.69% 77.43% 131.22% 35.86% 58.24% 1% 22.54% 37.62%
FCF Conversion (Net income) 217.41% 275.37% - 68.53% 92.79% 1.44% 35.48% 61.4%
Dividend per Share 2 1.000 1.000 1.000 1.000 2.500 1.833 1.833 2.100
Announcement Date 5/24/19 6/15/20 5/31/21 5/20/22 5/19/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 7,504 8,378 8,598 9,403 9,596 9,407 10,334 11,416 11,282 12,216 12,334 12,754 12,828 13,475
EBITDA 1 1,049 1,414 1,337 1,689 1,750 1,751 1,920 2,437 2,544 2,757 2,707 2,812 2,928 3,115
EBIT 1 584.4 969.2 889.6 1,230 1,289 1,283 1,445 1,948 1,971 2,194 2,118 2,253 2,332 2,398
Operating Margin 7.79% 11.57% 10.35% 13.08% 13.43% 13.64% 13.98% 17.06% 17.47% 17.96% 17.17% 17.66% 18.17% 17.8%
Earnings before Tax (EBT) 1 444.5 872.3 785.5 1,185 1,172 1,218 1,375 2,109 1,899 2,135 2,059 2,008 2,244 2,488
Net income 1 408.4 680.1 761.8 993.2 974.9 689.2 1,106 1,688 1,538 1,731 1,840 1,622 2,008 2,120
Net margin 5.44% 8.12% 8.86% 10.56% 10.16% 7.33% 10.7% 14.78% 13.63% 14.17% 14.91% 12.72% 15.65% 15.73%
EPS 2 2.010 3.350 3.750 4.890 4.800 3.390 5.440 8.310 7.570 8.530 9.060 7.400 9.530 10.23
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 2/5/21 5/31/21 8/5/21 11/10/21 2/4/22 5/20/22 8/8/22 11/9/22 2/8/23 5/19/23 8/2/23 - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 6,361 5,146 3,933 4,200 3,823 3,635 5,374 -
Net Cash position 1 - - - - - - - 93
Leverage (Debt/EBITDA) 2.21 x 1.217 x 2.16 x 0.6427 x 0.3959 x 0.3105 x 0.408 x -
Free Cash Flow 1 1,286 3,275 2,390 2,343 5,625 117 2,969 5,803
ROE (net income / shareholders' equity) 5.59% 10.7% -1.27% 26.2% 33.5% 31.2% 25.1% 22.8%
ROA (Net income/ Total Assets) - 4.59% -0.51% - 16.6% - - -
Assets 1 - 25,882 28,308 - 36,463 - - -
Book Value Per Share 2 52.90 55.60 54.80 73.40 105.0 143.0 177.0 226.0
Cash Flow per Share - - - - - - - -
Capex 1 1,500 1,159 701 2,507 5,220 10,949 9,811 7,374
Capex / Sales 5.24% 3.71% 2.71% 6.77% 11.54% 21.47% 16.93% 11.28%
Announcement Date 5/24/19 6/15/20 5/31/21 5/20/22 5/19/23 - - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Narayana Hrudayalaya Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1,276 INR
Average target price
1,422 INR
Spread / Average Target
+11.46%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
NARAYANA HRUDAYALAYA LIMITED Stock Narayana Hrudayalaya Limited
+6.12% 3.11B
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-20.16% 16.21B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+4.50% 12.44B
IHH HEALTHCARE Stock IHH Healthcare
+3.98% 11.58B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+9.72% 10.79B
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+23.61% 8.26B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-2.19% 7.68B
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+20.75% 7.2B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+4.49% 6.67B
GLOBAL HEALTH LIMITED Stock Global Health Limited
+50.89% 4.66B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. NH Stock
  4. Financials Narayana Hrudayalaya Limited